These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39007962)

  • 21. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production.
    Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W
    Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats.
    Debosschere Y; Depuydt E; Pauwelyn G; Beerts C; Van Hecke L; Verhaert L; Duchateau L; Saunders J; Tack L; Spaas JH
    Vet Immunol Immunopathol; 2020 Sep; 227():110083. PubMed ID: 32563854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
    Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?
    Moll G; Alm JJ; Davies LC; von Bahr L; Heldring N; Stenbeck-Funke L; Hamad OA; Hinsch R; Ignatowicz L; Locke M; Lönnies H; Lambris JD; Teramura Y; Nilsson-Ekdahl K; Nilsson B; Le Blanc K
    Stem Cells; 2014 Sep; 32(9):2430-42. PubMed ID: 24805247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
    Xie Q; Liu R; Jiang J; Peng J; Yang C; Zhang W; Wang S; Song J
    Stem Cell Res Ther; 2020 Dec; 11(1):519. PubMed ID: 33261658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulatory functions of oral mesenchymal stem cells: Novel force for tissue regeneration and disease therapy.
    Shang L; Shao J; Ge S
    J Leukoc Biol; 2021 Sep; 110(3):539-552. PubMed ID: 34184321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concise Review: Exploring Immunomodulatory Features of Mesenchymal Stromal Cells in Humanized Mouse Models.
    Mehler VJ; Burns C; Moore ML
    Stem Cells; 2019 Mar; 37(3):298-305. PubMed ID: 30395373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells.
    Ding DC; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):5-14. PubMed ID: 21396235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.
    Fu X; Chen Y; Xie FN; Dong P; Liu WB; Cao Y; Zhang WJ; Xiao R
    Tissue Eng Part A; 2015 Feb; 21(3-4):616-26. PubMed ID: 25256849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human embryonic stem cell-derived mesenchymal stromal cells.
    Hematti P
    Transfusion; 2011 Nov; 51 Suppl 4(Suppl 4):138S-144S. PubMed ID: 22074624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cell effects on T-cell effector pathways.
    Duffy MM; Ritter T; Ceredig R; Griffin MD
    Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis.
    Liu P; Qian Y; Liu X; Zhu X; Zhang X; Lv Y; Xiang J
    Front Immunol; 2022; 13():1096402. PubMed ID: 36685534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases.
    Jasim SA; Yumashev AV; Abdelbasset WK; Margiana R; Markov A; Suksatan W; Pineda B; Thangavelu L; Ahmadi SH
    Stem Cell Res Ther; 2022 Mar; 13(1):101. PubMed ID: 35255979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications.
    Dzobo K
    OMICS; 2021 Jun; 25(6):342-357. PubMed ID: 34115524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.
    Guo Y; Yu Y; Hu S; Chen Y; Shen Z
    Cell Death Dis; 2020 May; 11(5):349. PubMed ID: 32393744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.
    Schnabel LV; Abratte CM; Schimenti JC; Felippe MJ; Cassano JM; Southard TL; Cross JA; Fortier LA
    Regen Med; 2014; 9(5):621-35. PubMed ID: 24773530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-VCAM 1 Antibody-Coated Mesenchymal Stromal Cells Attenuate Experimental Colitis via Immunomodulation.
    Chen Q; Li Y; Chen Z; Du H; Wan J
    Med Sci Monit; 2019 Jun; 25():4457-4468. PubMed ID: 31201771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.